Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
CRO
One-third of data collected in trials may be unnecessary: study
Trials have been growing more complex, and the number of data points gathered in phase 3 trials grew from 929,203 to 3,560,201 between 2012 and 2020.
Darren Incorvaia
Sep 19, 2025 11:01am
Lilly rounds out orforglipron data ahead of obesity filings
Sep 17, 2025 9:00am
Novo pushes ahead with amylin after seeing ph. 3 tolerability
Sep 16, 2025 8:12am
Fierce Pharma
Novo Nordisk tells employees they must return to office Jan. 1
Sep 11, 2025 2:13pm
Fierce Pharma
Novo charts major restructuring, layoffs under new CEO
Sep 10, 2025 8:41am
FDA considers new liver trial endpoint, sending MASH shares up
Aug 28, 2025 11:25am